SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Macerich Co. – ‘8-K’ for 5/31/23

On:  Monday, 6/5/23, at 4:17pm ET   ·   For:  5/31/23   ·   Accession #:  1193125-23-160708   ·   File #:  1-12504

Previous ‘8-K’:  ‘8-K’ on / for 5/4/23   ·   Next:  ‘8-K’ on 8/7/23 for 8/4/23   ·   Latest:  ‘8-K’ on 3/26/24 for 3/20/24   ·   8 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 6/05/23  Macerich Co.                      8-K:5,9     5/31/23   11:363K                                   Donnelley … Solutions/FA

Current Report   —   Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     54K 
 2: EX-10.1     Material Contract                                   HTML    153K 
 6: R1          Document and Entity Information                     HTML     47K 
 9: XML         IDEA XML File -- Filing Summary                      XML     12K 
 7: XML         XBRL Instance -- d472381d8k_htm                      XML     14K 
 8: EXCEL       IDEA Workbook of Financial Report Info              XLSX      8K 
 4: EX-101.LAB  XBRL Labels -- mac-20230531_lab                      XML     55K 
 5: EX-101.PRE  XBRL Presentations -- mac-20230531_pre               XML     35K 
 3: EX-101.SCH  XBRL Schema -- mac-20230531                          XSD     12K 
10: JSON        XBRL Instance as JSON Data -- MetaLinks               12±    19K 
11: ZIP         XBRL Zipped Folder -- 0001193125-23-160708-xbrl      Zip     53K 


‘8-K’   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 iX: 
  8-K  
 i MACERICH CO  i MD  i false  i 0000912242 0000912242 2023-05-31 2023-05-31

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

FORM  i 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported):  i May 31, 2023

 

 

THE MACERICH COMPANY

(Exact Name of Registrant as Specified in Charter)

 

 

 

MARYLAND    i 1-12504    i 95-4448705

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 i 401 Wilshire Boulevard,  i Suite 700,  i Santa Monica,  i California  i 90401

(Address of Principal Executive Offices) (Zip Code)

Registrant’s telephone number, including area code  i (310)  i 394-6000

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

 i 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 i 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 i 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 i 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

symbol(s)

 

Name of each exchange

on which registered

 i Common stock of The Macerich Company, $0.01 par value per share    i MAC    i The New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company   i 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 


ITEM 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

The Board of Directors (the “Board”) of The Macerich Company (the “Company”) previously approved, subject to stockholder approval, The Macerich Company 2003 Equity Incentive Plan, as amended and restated (the “2003 Incentive Plan”), that would increase the aggregate share limit by an additional 5,200,000 shares and extend the term of the 2003 Incentive Plan until May 31, 2033. As reported under Item 5.07 below, the Company’s stockholders approved the 2003 Incentive Plan at its Annual Meeting of Stockholders held on May 31, 2023 (the “Annual Meeting”). The 2003 Incentive Plan is filed as Exhibit 10.1 hereto and incorporated herein by reference.

 

ITEM 5.07

Submission of Matters to a Vote of Security Holders.

The Company held the Annual Meeting on May 31, 2023. At the Annual Meeting, the Company’s stockholders (1) elected the ten nominees listed below to serve as directors until the next annual meeting of stockholders and until their respective successors are duly elected and qualified, (2) approved the 2003 Incentive Plan; (3) approved the compensation of the Company’s named executive officers; (4) approved a frequency of one year for the future advisory votes on the Company’s named executive officer compensation and (5) ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023. Based on the approval of a frequency of one year, the Board currently intends for the Company to submit an advisory vote to its stockholders on the compensation of its named executive officers every year until the next required vote on the frequency of future advisory votes on named executive officer compensation.

 

Proposal 1:

Election of Ten Directors to Serve Until the Next Annual Meeting of Stockholders and Until Their Respective Successors are Duly Elected and Qualified.

 

     For      Against      Abstentions      Broker Non-
Votes
 

Peggy Alford

     150,458,292        10,262,830        312,603        23,520,719  

Eric K. Brandt

     145,619,589        15,105,105        309,031        23,520,719  

Edward C. Coppola

     157,166,367        3,596,082        271,276        23,520,719  

Steven R. Hash

     157,010,649        3,718,474        304,602        23,520,719  

Enrique Hernandez, Jr.

     158,806,847        1,911,993        314,885        23,520,719  

Daniel J. Hirsch

     139,418,152        21,313,973        301,600        23,520,719  

Marianne Lowenthal

     159,024,520        1,696,137        313,068        23,520,719  

Thomas E. O’Hern

     158,915,828        1,846,044        271,853        23,520,719  

Steven L. Soboroff

     157,335,680        3,378,090        319,955        23,520,719  

Andrea M. Stephen

     157,585,666        3,131,600        316,459        23,520,719  


Proposal 2:

Approval of the 2003 Incentive Plan.

 

For

 

Against

 

Abstentions

 

Broker Non-

Votes

155,172,341   5,577,292   284,092   23,520,719

 

Proposal 3:

Advisory Vote to Approve the Compensation of the Company’s Named Executive Officers.

 

For

 

Against

 

Abstentions

 

Broker Non-

Votes

154,271,032   6,415,999   346,694   23,520,719

 

Proposal 4:

Advisory Vote on the Frequency of Future Advisory Votes on the Company’s Named Executive Officer Compensation.

 

1 Year

 

2 Years

 

3 Years

 

Abstentions

 

Broker Non-Votes

155,061,086   87,981   5,600,515   284,143   23,520,719

 

Proposal 5:

Ratification of the Appointment of KPMG LLP as the Company’s Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2023.

 

For

 

Against

 

Abstentions

182,569,166   1,725,358   259,920

There were no broker non-votes for Proposal 5.

 

ITEM 9.01

Financial Statements and Exhibits.

 

(d)

Exhibits

 

10.1*    The Macerich Company 2003 Equity Incentive Plan, as amended and restated as of May 31, 2023.
104    Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

*

Represents a management contract, or compensatory plan, contract or arrangement required to be filed pursuant to Regulation S-K.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, The Macerich Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    THE MACERICH COMPANY
    By:   ANN C. MENARD
June 5, 2023    

/s/ Ann C. Menard

    Senior Executive Vice President,
Chief Legal Officer and Secretary

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
5/31/33
12/31/23
Filed on:6/5/23
For Period end:5/31/234
 List all Filings 


8 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/26/24  Macerich Co.                      10-K       12/31/23  129:15M
 8/09/23  Macerich Co.                      10-Q        6/30/23  102:9.5M
 8/07/23  Macerich Co.                      424B5       8/04/23    2:654K                                   Donnelley … Solutions/FA
 8/04/23  Macerich Co.                      424B7                  2:703K                                   Donnelley … Solutions/FA
 8/04/23  Macerich Co.                      424B2                  2:704K                                   Donnelley … Solutions/FA
 8/04/23  Macerich Co.                      424B2                  2:809K                                   Donnelley … Solutions/FA
 8/04/23  Macerich Co.                      S-3ASR      8/04/23    8:1.3M                                   Donnelley … Solutions/FA
 6/06/23  Macerich Co.                      S-8         6/06/23    4:82K                                    Donnelley … Solutions/FA
Top
Filing Submission 0001193125-23-160708   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 23, 5:32:27.2pm ET